
Sustainable and profitable: Evonik keeps growing
Sales, adjusted EBITDA and free cash flow all increased more than 20 percent in 2021 compared with the previous year. ... MORE
Sales, adjusted EBITDA and free cash flow all increased more than 20 percent in 2021 compared with the previous year. ... MORE
As the builders of the future, we’re working to improve people’s lives. By thinking beyond chemistry. Today and tomorrow. In more than 100 countries, we benefit from our proximity to customers, and our leading market positions. Read more in our e-paper. ... MORE
We think beyond the bounds of chemistry ... to make the world a better place day by day. Today and tomorrow. We are the future of chemistry. We are Evonik. ... MORE
The innovation magazine ELEMENTS by Evonik offers informative science journalism with social, economic and political classification. ... MORE
Living organisms are a source of hope: Biotechnology is regarded as the driving force of a new industrial revolution. It promises to deliver pioneering innovations ranging from medications to biofuel. ... MORE
Concrete is the world’s top-selling construction material. What potential does it have for the future? And how are researchers extending its lifetime and making it more sustainable? ... MORE
Less waste of resources, less waste, less emissions—the chemical industry is contributing to the establishment of a sustainable circular economy by helping to close energy and material cycles. Read more in our ELEMENTS magazine dossier on circular economy. ... MORE
Evonik is celebrating the start of construction of the world’s first commercial rhamnolipid production facility with a groundbreaking ceremony today. ... MORE
CALOSTAT®, Evonik’s brand of mineral-based, high-performance insulating material, has won gold in the “Excellent Brands: Building & Elements” category for this year’s German Brand Award. ... MORE
Evonik Venture Capital has invested in two sustainability funds: Azolla Ventures I and the Chrysalix Venture Capital’s Carbon Neutrality Fund. ... MORE
The cell culture ingredient cQrex® AC, a chemically defined and highly soluble source of L-cystine, increases efficiency and productivity in bioprocesses for producing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells. ... MORE
The new plant will broadly position the Group for future growth in mRNA-based therapies and strengthen its leading role as a strategic partner for pharmaceutical companies worldwide. ... MORE
... MORE
As the builders of the future, Evonik is working to improve people’s lives. By thinking beyond chemistry. Today and tomorrow. In more than 100 countries, we benefit from our proximity to customers, and our leading market positions. Read more in our e-paper. ... MORE
Here you'll find Evonik's publications for download or as an ePaper. ... MORE
"Soon You'll know more about us" is a brochure that provides information on Evonik - short and to the point. ... MORE
Get fascinating insights into the research Evonik is conducting, and its social relevance, by subscribing to the free digital edition. ... MORE
Here you'll find a selection of press photos from Evonik in printable quality for download. The photos available here are free of charge for news and editorial purposes covering Evonik. ... MORE
Welcome to Evonik's YouTube channel ... MORE
Attractive businesses, an extensive product portfolio, an ability to innovate—this is what the name Evonik represents. As a leading specialty chemicals company, we make life better on a daily basis—that is to say, more convenient, more practical, and safer. Click here to watch the new corporate video. ... MORE
Here you can find our news on Social Media. As colorful and diverse as the world of Evonik are the Social Media Channels of the company. Follow us - on LinkedIn, Twitter, YouTube, Facebook, Instagram and TikTok. ... MORE
for journalists ... MORE